The study by Barsam et al of patients with immune thrombocytopenia (ITP) in this issue of Blood suggests that stimulation of megakaryopoiesis with thrombopoietin-receptor agonists does not always result in improvement of the platelet count because of ineffective thrombopoiesis.[1][1] In the first
No takes yet. Share an insight, caveat, or question.
Roberto Stasi (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: